These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 12407379)

  • 1. Gene transfection of hepatocyte growth factor attenuates cardiac remodeling in the canine heart: A novel gene therapy for cardiomyopathy.
    Ahmet I; Sawa Y; Iwata K; Matsuda H
    J Thorac Cardiovasc Surg; 2002 Nov; 124(5):957-63. PubMed ID: 12407379
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiogenesis and antifibrotic action by hepatocyte growth factor in cardiomyopathy.
    Taniyama Y; Morishita R; Aoki M; Hiraoka K; Yamasaki K; Hashiya N; Matsumoto K; Nakamura T; Kaneda Y; Ogihara T
    Hypertension; 2002 Jul; 40(1):47-53. PubMed ID: 12105137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene transfection with human hepatocyte growth factor complementary DNA plasmids attenuates cardiac remodeling after acute myocardial infarction in goat hearts implanted with ventricular assist devices.
    Shirakawa Y; Sawa Y; Takewa Y; Tatsumi E; Kaneda Y; Taenaka Y; Matsuda H
    J Thorac Cardiovasc Surg; 2005 Sep; 130(3):624-32. PubMed ID: 16153905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene transfection of hepatocyte growth factor attenuates the progression of cardiac remodeling in the hypertrophied heart.
    Iwata K; Sawa Y; Kitagawa-Sakakida S; Kawaguchi N; Matsuura N; Nakamura T; Matsuda H
    J Thorac Cardiovasc Surg; 2005 Sep; 130(3):719-25. PubMed ID: 16153919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A slow-releasing form of prostacyclin agonist (ONO1301SR) enhances endogenous secretion of multiple cardiotherapeutic cytokines and improves cardiac function in a rapid-pacing-induced model of canine heart failure.
    Shirasaka T; Miyagawa S; Fukushima S; Saito A; Shiozaki M; Kawaguchi N; Matsuura N; Nakatani S; Sakai Y; Daimon T; Okita Y; Sawa Y
    J Thorac Cardiovasc Surg; 2013 Aug; 146(2):413-21. PubMed ID: 23541854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene transfer of hepatocyte growth factor improves angiogenesis and function of chronic ischemic myocardium in canine heart.
    Ahmet I; Sawa Y; Yamaguchi T; Matsuda H
    Ann Thorac Surg; 2003 Apr; 75(4):1283-7. PubMed ID: 12683576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthetic prostacyclin agonist, ONO1301, enhances endogenous myocardial repair in a hamster model of dilated cardiomyopathy: a promising regenerative therapy for the failing heart.
    Ishimaru K; Miyagawa S; Fukushima S; Saito A; Sakai Y; Ueno T; Sawa Y
    J Thorac Cardiovasc Surg; 2013 Dec; 146(6):1516-25. PubMed ID: 24229503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improvement of heart function in postinfarct heart failure swine models after hepatocyte growth factor gene transfer: comparison of low-, medium- and high-dose groups.
    Yang ZJ; Chen B; Sheng Z; Zhang DG; Jia EZ; Wang W; Ma DC; Zhu TB; Wang LS; Li CJ; Wang H; Cao KJ; Ma WZ
    Mol Biol Rep; 2010 Apr; 37(4):2075-81. PubMed ID: 19680789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of dilated cardiomyopathy with electroporation of hepatocyte growth factor gene into skeletal muscle.
    Komamura K; Tatsumi R; Miyazaki J; Matsumoto K; Yamato E; Nakamura T; Shimizu Y; Nakatani T; Kitamura S; Tomoike H; Kitakaze M; Kangawa K; Miyatake K
    Hypertension; 2004 Sep; 44(3):365-71. PubMed ID: 15289469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myocardial regeneration therapy for heart failure: hepatocyte growth factor enhances the effect of cellular cardiomyoplasty.
    Miyagawa S; Sawa Y; Taketani S; Kawaguchi N; Nakamura T; Matsuura N; Matsuda H
    Circulation; 2002 May; 105(21):2556-61. PubMed ID: 12034665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Cardiac Resynchronization Therapy on Myocardial Fibrosis and Relevant Cytokines in a Canine Model With Experimental Heart Failure.
    Wang J; Gong X; Chen H; Qin S; Zhou N; Su Y; Ge J
    J Cardiovasc Electrophysiol; 2017 Apr; 28(4):438-445. PubMed ID: 28127817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiogenic and antifibrotic actions of hepatocyte growth factor improve cardiac dysfunction in porcine ischemic cardiomyopathy.
    Azuma J; Taniyama Y; Takeya Y; Iekushi K; Aoki M; Dosaka N; Matsumoto K; Nakamura T; Ogihara T; Morishita R
    Gene Ther; 2006 Aug; 13(16):1206-13. PubMed ID: 16625244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiogenic and pleiotropic effects of VEGF165 and HGF combined gene therapy in a rat model of myocardial infarction.
    Makarevich PI; Dergilev KV; Tsokolaeva ZI; Boldyreva MA; Shevchenko EK; Gluhanyuk EV; Gallinger JO; Menshikov MY; Parfyonova YV
    PLoS One; 2018; 13(5):e0197566. PubMed ID: 29787588
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of gene transfer with hepatocyte growth factor for pulmonary vascular hypoplasia in neonatal porcine model.
    Ono M; Sawa Y; Miyamoto Y; Fukushima N; Ichikawa H; Ishizaka T; Kaneda Y; Matsuda H
    J Thorac Cardiovasc Surg; 2005 Apr; 129(4):740-5. PubMed ID: 15821638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of adenovirus-mediated delivery of the human hepatocyte growth factor gene in experimental radiation-induced heart disease.
    Hu S; Chen Y; Li L; Chen J; Wu B; Zhou X; Zhi G; Li Q; Wang R; Duan H; Guo Z; Yang Y; Xiao F; Wang H; Wang L
    Int J Radiat Oncol Biol Phys; 2009 Dec; 75(5):1537-44. PubMed ID: 19931736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatocyte growth factor prevents ventricular remodeling and dysfunction in mice via Akt pathway and angiogenesis.
    Wang Y; Ahmad N; Wani MA; Ashraf M
    J Mol Cell Cardiol; 2004 Nov; 37(5):1041-52. PubMed ID: 15522281
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene transfer of hepatocyte growth factor attenuates postinfarction heart failure.
    Jayasankar V; Woo YJ; Bish LT; Pirolli TJ; Chatterjee S; Berry MF; Burdick J; Gardner TJ; Sweeney HL
    Circulation; 2003 Sep; 108 Suppl 1():II230-6. PubMed ID: 12970238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatocyte growth factor and granulocyte colony-stimulating factor form a combined neovasculogenic therapy for ischemic cardiomyopathy.
    Guo YH; He JG; Wu JL; Yang L; Zhang DS; Tan XY; Qi RD
    Cytotherapy; 2008; 10(8):857-67. PubMed ID: 18956268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improvement of cardiac function in the failing rat heart after transfer of skeletal myoblasts engineered to overexpress placental growth factor.
    Gmeiner M; Zimpfer D; Holfeld J; Seebacher G; Abraham D; Grimm M; Aharinejad S
    J Thorac Cardiovasc Surg; 2011 May; 141(5):1238-45. PubMed ID: 21329947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prolonged mechanical unloading preserves myocardial contractility but impairs relaxation in rat heart of dilated cardiomyopathy accompanied by myocardial stiffness and apoptosis.
    Muranaka H; Marui A; Tsukashita M; Wang J; Nakano J; Ikeda T; Sakata R
    J Thorac Cardiovasc Surg; 2010 Oct; 140(4):916-22. PubMed ID: 20381089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.